Do all women need LH for ovarian stimulation?;Stimulation ovarienne: La LH exogène est-elle nécessaire chez toutes les patientes?

Gynecologie Obstetrique et Fertilite

Volumn 30, Issue 11, 2002, Pages 890-895

  Loumaye, E ^a  

^a NONE   (France)

Author keywords

Ceiling; Infertility; LH; Recombinant LH; Threshold

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG INDICATION; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HORMONE DEFICIENCY; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; OVARY CYCLE; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION;

EID: 0036853377     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(02)00461-7     Document Type: Article

References (16)

1. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-91.
2. Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotrophin or purified follicle stimulating hormone in hypogonadotrophic hypogonadism patients. Fertil Steril 1991;56:1048-53.
3. The European recombinant human LH study group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle stimulating hormone (FSH) induced follicular development in LH and FSH deficient anovulatory women: A dose finding study. J Clin Endocrinol Metab 1998;83:1507-14 (5).
4. Fleming R, Lloyd F, Herbert M, Fenwick J, Griffiths, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum. Reprod 1998;13:1788-92.
5. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Hum Reprod 2000;15:1003-8.
6. Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, et al. Suppression of LH during ovarian stimulation: Analysing threshold values and effects on ovarian response and the out-come of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 2001;8:1636-43.
7. Stokman PG, de Leeuw R, van den Wijngaard HA, Kloosterboer HJ, Vemer HM, Sanders AL. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril, Jul 1993;60:175-8 (1).
8. Le Cotonnec JY, Porchet HC, Beltrami V, Munafo A. Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertil Steril, Feb 1998;69:189-94 (2).
9. Le Cotonnec JY, Loumaye E, Porchet HC, Beltrami V, Munafo A. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertil Steril, Feb 1998;69:201-9 (2).
10. Le Cotonnec JY, Porchet HC, Beltrami V, Munafo A. Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. Fertil Steril, Feb 1998;69:195-200.
11. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, et al. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659-63 (8).
12. Yong EL, Baird DT, Yates R, Reichert Jr LE, Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab 1992;74:842-9 (4).
13. Arguinzoniz M, Duerr-Meyers L, Engrand P, Piazzi A, Loumaye E. The efficacy and safety of recombinant human luteinizing hormone for minimizing the number of pre-ovulatory follicles in WHO group 1 anovulatory women treated with r-hFSH. Abstract O-176. Hum. Reprod 00;Vol. 15 Abstract book 1.
14. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli De Fatis C, et al. Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab 2001;86:337-43 (1).
15. Loumaye E, Engrand P, Howles CM, O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997;67:889-99 (5).
16. Kelly E, Werlin L, Weathersbee P, Nebiolo L, Ferrande L. Publication en cours 2001.